From 'Beauty-Aging' Philosophy to Korea's Premium Clinic Operating Model
On the 19th, Myoungjin Oh, MD, Chief Representative Medical Director of Maison Prive Clinic, hosted a special briefing and lecture on the Korean medical aesthetics market for representatives of Laser Clinics Australia (LCA), Australia's largest medical aesthetics group.< Read Original Article on Medical Today >
Celebrating his 21st anniversary of clinical practice this year, Myoungjin Oh, MD, Chief is a recognized K-aesthetics trend leader who has overseen aesthetic care for prominent domestic and international figures. This lecture was organized to share the evolution of Korea's medical aesthetic industry and premium clinic operational expertise within the rapidly changing global market.
During the session, Dr. Oh presented under the theme 'How Korea's Medical Aesthetics Market Has Evolved.' He detailed how the Korean market expanded from cosmetics-centered K-beauty into specialized medical realms (Aesthetics), including dermatology and plastic surgery.
He explained that the industry paradigm is shifting from single-area correction toward comprehensive conditioning of skin and tissue architecture—utilizing skin boosters, collagen synthesis stimulators, and regenerative medicine. In particular, Dr. Oh highlighted Maison Prive's signature 'Beauty-Aging' philosophy—an approach moving beyond conventional anti-aging to embrace the passage of time while preserving each individual's natural, profound beauty—which drew an enthusiastic response from the international audience.
An in-depth analysis of the operational structures in the Korean medical aesthetics market followed. Dr. Oh categorized the market landscape into the 'Volume Model,' characterized by scale and operational efficiency, and the 'Premium Model,' centered on personalized 1:1 consultation and exceptional patient experiences. He also introduced the Management Service Organization (MSO) framework that enables medical teams to focus strictly on patient care, alongside a systematic model managing the entire patient journey.
In the concluding segment, Dr. Oh highlighted global expansion cases of Korean-developed pharmaceuticals and medical devices, including botulinum toxins and skin boosters. He analyzed regulatory and market differences between Korea and Australia, engaging in deep discussions regarding future collaboration opportunities.
Myoungjin Oh, MD, Chief Representative Director of Maison Prive, stated, "The true competitiveness of Korean medical aesthetics extends beyond advanced devices or technical skill; it lies in a system that carefully understands each patient's unique architecture and designs tailored medical care and experiences. It was deeply meaningful to share the evolution of Korean aesthetics and Maison Prive's Beauty-Aging philosophy with international leaders."
